Diabetic Peripheral Neuropathy (DPN) Clinical Trial
Official title:
Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy
This study will be an observational cohort study utilizing administrative claims data with 100 patients randomly selected taking Metanx® meeting the inclusion and exclusion criteria and 400 propensity score matched patients meeting the same criteria to serve as a control cohort for analyses. This data includes medical, and pharmacy claims from the HealthCore Integrated Research Database for claims submitted during the time period of 01/01/2002 through 06/30/2007.
The control patients will be matched at a ratio of 4:1 with the Metanx® patients. Covariates
used to select the propensity matched patients will include: age; gender; health plan type
and region; DCI score; presence/absence of nephropathy; ischemic heart disease;
cerebrovascular disease; neoplasm; insulin use; and all-cause health plan costs in the
6-mont pre-index period.
Claims information about patients selected for the study will be followed longitudinally to
the end of data availability. This data stream will be used to determine treatment patterns
for Metanx®, healthcare resource utilization, and cost.
;
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04832464 -
BRACE(Balance, Resistance, Aerobic and Cognitive Exercise) Protocol for Diabetic).Peripheral Neuropathic Patients.
|
N/A | |
| Completed |
NCT05319275 -
Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN
|
Phase 3 | |
| Completed |
NCT03865953 -
Oral LAT8881 in Neuropathic Pain
|
Phase 2 |